Sun Pharmaceutical Industries’ arm – Caraco Pharmaceutical Laboratories, has initiated a recall of multiple lots of Cephalexin capsules from the US market. The recall of the 340,553 units of 500 mg and 113,677 units of 250 mg bottles is voluntarily initiated by the company through a letter to USFDA in June under ‘Class-II’ classification.
Real Time News & Trading Trends Keep Liking #EpicResearch
Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+
For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH
0 comments:
Post a Comment